Wondering how to use Neogenomics in a sentence? Below are 10+ example sentences from authentic English texts. .
Neogenomics in a sentence
Using Neogenomics
- In the example corpus, neogenomics often appears in combinations such as: neogenomics by, in neogenomics, neogenomics inc.
Context around Neogenomics
- Average sentence length in these examples: 16.6 words
- Position in the sentence: 3 start, 12 middle, 0 end
- Sentence types: 15 statements, 0 questions, 0 exclamations
Corpus analysis for Neogenomics
- In this selection, "neogenomics" usually appears in the middle of the sentence. The average example has 16.6 words, and this corpus slice is mostly made up of statements.
- Around the word, marketbeat, avoid, inc and presently stand out and add context to how "neogenomics" is used.
- Recognizable usage signals include coverage on neogenomics in a and forecast that neogenomics inc will. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "neogenomics" sits close to words such as aaon, abbv and abdalla, which helps place it inside the broader word index.
Example types with neogenomics
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
NeoGenomics has higher revenue and earnings than Suncast Solar Energy. (10 words)
NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida. (13 words)
FMR LLC grew its position in NeoGenomics by 7.6% in the 3rd quarter. (14 words)
Therefore, the recommendation is to avoid NeoGenomics, Inc. shares at these levels even as management has strung together a string of commendable quarterly results. (24 words)
Canada Pension Plan Investment Board bought a new stake in NeoGenomics in the second quarter valued at about $57,000. (20 words)
According to MarketBeat, NeoGenomics presently has a consensus rating of “Moderate Buy” and an average price target of $18. (19 words)
Example sentences (15)
According to MarketBeat, NeoGenomics presently has a consensus rating of “Moderate Buy” and an average price target of $18.
Therefore, the recommendation is to avoid NeoGenomics, Inc. shares at these levels even as management has strung together a string of commendable quarterly results.
Tower Research Capital LLC TRC increased its stake in shares of NeoGenomics by 165.6% in the 1st quarter.
As a group, analysts forecast that NeoGenomics, Inc. will post -0.19 EPS for the current year.
Canada Pension Plan Investment Board bought a new stake in NeoGenomics in the second quarter valued at about $57,000.
Finally, Jefferies Financial Group initiated coverage on NeoGenomics in a research report on Tuesday, December 10th.
FMR LLC grew its position in NeoGenomics by 7.6% in the 3rd quarter.
Quadrant Capital Group LLC increased its stake in shares of NeoGenomics by 22.0% during the fourth quarter.
NeoGenomics has higher revenue and earnings than Suncast Solar Energy.
NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Finally, Eagle Asset Management Inc. raised its position in NeoGenomics by 19.0% in the first quarter.
LPL Financial LLC increased its holdings in NeoGenomics by 2.4% in the second quarter.
Vanguard Group Inc. raised its position in NeoGenomics by 41.6% in the second quarter.
Yorktown Management & Research Co Inc increased its holdings in NeoGenomics by 4.6% in the second quarter.
Vanguard Group Inc raised its stake in NeoGenomics by 24.0% during the third quarter.
Common combinations with neogenomics
These word pairs occur most frequently in English texts:
- neogenomics by 8×
- in neogenomics 7×
- neogenomics inc 3×
- of neogenomics 2×
- neogenomics in 2×